Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $5,488,828    

Indirect Value

   $5,163      
Total Shares   102,001      
Total Value   $5,493,990      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $3,457,469 Acelyrin, Inc. $32,780 Madrigal Pharmaceuticals Inc $1,916,379 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $3,457,469 Acelyrin, Inc. $32,780 Madrigal Pharmaceuticals Inc $1,916,379
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-11 4 S $38.21 $522,511 D/D (13,674) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-12 4 S $37.88 $503,452 D/D (13,290) 0 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-10-12 4 S $38.22 $133,158 D/D (3,484) 68,324 0 %
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-02-23 4 OE $4.10 $25,351 D/D 5,692 5,692 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-11 4 OE $7.00 $118,596 D/D 13,674 13,674 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-12 4 OE $9.50 $126,255 D/D 13,290 13,290 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-27 4 OE $5.00 $30,380 D/D 6,076 6,076 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-06-08 4 OE $4.10 $69,620 D/D 16,119 16,119 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-09-18 4 OE $5.10 $64,951 D/D 8,912 8,912 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2016-08-01 4 OE $3.30 $50,002 D/D 15,152 15,152 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 OE $7.00 $78,095 D/D 10,235 4,300 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 OE $7.00 $1,736,009 D/D 93,392 6,885 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-07-11 4 OE $25.08 $585,618 D/D 23,350 23,350 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-07-28 4 OE $0.00 $0 D/D 17,500 116,271 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-08-31 4 OE $0.00 $0 D/D 17,500 107,684 0 -
PTLA Portola Pharmaceuticals I... Senior VP and CFOOfficer   •       –      –    2013-05-21 3 IO $0.00 $0 D/D 0 69,649 -
MDGL Madrigal Pharmaceuticals ... SVP and CFO   •       –      –    2024-03-11 3 IO $0.00 $0 D/D 0 8,875 %
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2016-03-02 4 D $31.75 $48,387 D/D (1,524) 10,476 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-08-16 4 D $54.86 $199,416 D/D (3,635) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-03-02 4 D $32.53 $219,090 D/D (6,735) 31,040 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-03-08 4 D $38.69 $483,531 D/D (12,474) 61,442 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-05-22 4 D $40.82 $102,621 D/D (2,514) 116,271 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-08-23 4 D $26.05 $229,084 D/D (8,794) 107,477 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-09-04 4 D $29.18 $259,203 D/D (8,884) 98,800 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-15 4 D $24.25 $21,049 D/D (868) 97,932 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us